(lp0
S"aTyr Pharma to Present at Cowen and Company 37th Annual Health Care Conference PR Newswire  - Mar 1, 2017 SAN DIEGO, March 1, 2017 /PRNewswire/ -- aTyr Pharma, Inc. , a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, today announced the Company's&nbsp;...aTyr Pharma, Inc.  recently purchased by insider SCHIMMEL PAUL - Post AnalystAnalysts showing optimistic trends for: aTyr Pharma Inc.  - News Oracle"
p1
aS'aTyr Pharma Reports Promising Signals of Clinical Activity in Multiple Rare ... PR Newswire  - Dec 13, 2016 SAN DIEGO, Dec. 13, 2016 /PRNewswire/ -- aTyr Pharma, Inc. , a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, today announced clinical results from&nbsp;...'
p2
aS'aTyr Pharma Inc  PT Raised to $4.00 at Citigroup Inc The Cerbat Gem - 12 hours ago aTyr Pharma logo aTyr Pharma Inc  had its price target increased by stock analysts at Citigroup Inc from $3.00 to $4.00 in a research report issued to clients and investors on Monday.aTyr Pharma Inc  Expected to Earn Q1 2017 Earnings of  Per Share - Chaffey Breeze'
p3
aS'aTyr Pharma Receives EMA Orphan Drug Designation for the Treatment of Limb ... PR Newswire  - Mar 3, 2017 SAN DIEGO, March 3, 2017 /PRNewswire/ -- aTyr Pharma, Inc. , a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, today announced that the European&nbsp;...aTyr Pharma  Receives FDA Orphan Drug Designation for Treatment of LGMD ... - StreetInsider.comBRIEF-Atyr Pharma receives EMA orphan drug designation for the treatment of ... - Reuters'
p4
aS"aTyr Pharma Presents Additional Data for Resolaris Phase 1b/2 Trial in Adult ... PR Newswire  - Oct 6, 2016 SAN DIEGO, Oct. 6, 2016 /PRNewswire/ -- aTyr Pharma, Inc. , today announced that additional clinical data from aTyr's Phase 1b/2 Trial  in adult patients with FSHD were presented at the 21st International Congress of the World Muscle&nbsp;..."
p5
aS'Crunching the Numbers for aTyr Pharma Inc  Baxter Review - 12 hours ago Investors and Traders using technical analysis to study stocks may be looking at the ATR or Average True Range. Presently, aTyr Pharma Inc  has a 14-day ATR of 0.22. The Average True Range is an investor tool used to gauge stock volatility. The ...'
p6
aS'Atyr Pharma reports 4Q loss Yahoo Finance - Mar 16, 2017 SAN DIEGO  _ Atyr Pharma Inc.  on Thursday reported a loss of $12.6 million in its fourth quarter. On a per-share basis, the San Diego-based company said it had a loss of 53 cents.How has aTyr Pharma, Inc. performed recently? - The Daily LeicesteraTyr Pharma  Reaches $3.80 After 8.00% Up Move; Schwab Charles ... - HuronReport'
p7
aS'aTyr Pharma Announces Issuance of US Patent That Extends Patent Protection of ... Yahoo Finance - Mar 15, 2017 SAN DIEGO, March 15, 2017 /PRNewswire/ -- aTyr Pharma, Inc. , a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, today announced the issuance of US Patent&nbsp;...'
p8
aS'aTyr Pharma Announces Second Quarter 2016 Operating Results PR Newswire  - Aug 10, 2016 SAN DIEGO, Aug. 10, 2016 /PRNewswire/ -- aTyr Pharma, Inc. , a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, today announced operating results for&nbsp;...'
p9
aS'aTyr Pharma Enters into $20 Million Credit Facility PR Newswire  - Nov 21, 2016 SAN DIEGO, Nov. 21, 2016 /PRNewswire/ -- aTyr Pharma, Inc. , a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, today announced it has entered into a&nbsp;...'
p10
a.